Fueling Next-Generation MS Disease Progression Research with Valhalla Foundation Support – Read the Release

Contact Us

Proteomic Serum Biomarker Signatures Associated with Patient Reported Outcomes in Multiple Sclerosis

January 20, 2022inByCommentNo Comments
Click here